Title : Clinical and histological aspects of CNV formation: studies in an animal model.

Pub. Date : 2008 Sep

PMID : 18783494






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bevacizumab, a pan VEGF A antibody, was found to reduce both the proliferation of endothelial cells in CNV membranes and the propensity to leak in fluorescein angiograms. Fluorescein vascular endothelial growth factor A Homo sapiens